arginine and fostriecin

arginine has been researched along with fostriecin in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Frosina, G; Rossi, O	1
Darzynkiewicz, Z; Del Bino, G; Hotz, MA; Lassota, P; Traganos, F	1
Anderson, H; Harder, KW; Hung, SM; Jirik, FR; Roberge, M; Tudan, C	1
de Jong, RS; de Vries, EG; Groen, HJ; Höppener, FJ; Mulder, NH; Sleijfer, DT; Uges, DR; van der Graaf, WT; Willemse, PH	1

Trials

1 trial(s) available for arginine and fostriecin

Article	Year
Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin. British journal of cancer, 1999, Volume: 79, Issue:5-6 Topics: Adult; Aged; Alanine Transaminase; Alkenes; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Polyenes; Pyrones; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured	1999

Article

Year

Phase I and pharmacokinetic study of the topoisomerase II catalytic inhibitor fostriecin.

British journal of cancer, 1999, Volume: 79, Issue:5-6

Topics: Adult; Aged; Alanine Transaminase; Alkenes; Antibiotics, Antineoplastic; Aspartate Aminotransferases; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Colorectal Neoplasms; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Half-Life; Humans; Lung Neoplasms; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Polyenes; Pyrones; Teniposide; Topoisomerase II Inhibitors; Tumor Cells, Cultured

1999

Other Studies

3 other study(ies) available for arginine and fostriecin

Article	Year
Effect of topoisomerase poisoning by antitumor drugs VM 26, fostriecin and camptothecin on DNA repair replication by mammalian cell extracts. Carcinogenesis, 1992, Volume: 13, Issue:8 Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Camptothecin; Cell Extracts; Cricetinae; DNA Repair; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Dose-Response Relationship, Drug; In Vitro Techniques; Polyenes; Pyrones; Teniposide	1992
Cytostatic and cytotoxic effects of fostriecin on human promyelocytic HL-60 and lymphocytic MOLT-4 leukemic cells. Cancer research, 1992, Mar-15, Volume: 52, Issue:6 Topics: Alkenes; Amsacrine; Antibiotics, Antineoplastic; Cell Cycle; DNA, Neoplasm; Humans; Leukemia, Lymphoid; Leukemia, Promyelocytic, Acute; Polyenes; Pyrones; Teniposide; Tumor Cells, Cultured	1992
Antitumor drug fostriecin inhibits the mitotic entry checkpoint and protein phosphatases 1 and 2A. Cancer research, 1994, Dec-01, Volume: 54, Issue:23 Topics: Alkenes; Animals; Antibiotics, Antineoplastic; Camptothecin; CDC2 Protein Kinase; Cells, Cultured; Cricetinae; DNA Damage; DNA Replication; G2 Phase; Mitosis; Phosphoprotein Phosphatases; Polyenes; Protein Phosphatase 1; Protein Phosphatase 2; Pyrones; Teniposide	1994